The Society for Immunotherapy of Cancer (SITC) published it's first clinical practice guideline (CPG) on immunotherapy for the treatment of Acute Leukemia in the Journal for ImmunoTherapy of Cancer on October 19, 2020.SITC's Cancer Immunotherapy Guidelines program is a collection of CPGs developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations. SITC uses as a model the Institute of Medicine's 2011 "Standards for Developing Trustworthy Clinical Practice Guidelines" to ensure the recommendations are unbiased, transparent and balanced will aid oncologists in effective clinical decision-making concerning patient selection, toxicity management, response evaluation, and the sequencing or combination of therapies, among other topics. This Acute Leukemia CPG was developed collaboratively through the efforts of an expert panel that convened to discuss the current therapeutic landscape and covers FDA-approved immunotherapies for acute lymphoblastic and acute myeloid leukemia, as well as discussion of promising emerging treatment modalities, and patient quality of life issues.
Published October 19, 2020 in the Journal for ImmunoTherapy of Cancer (JITC) as "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on Immunotherapy for the treatment of acute leukemia"
Learn more about immunotherapy treatment standards for acute leukemia and hear about the The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia in this free one-hour webinar. SITC hosted this session on January 11, 2021, featuring members of the Cancer Immunotherapy Guideline – Acute Leukemia Expert Panel.
VIEW ON-DEMAND WEBINAR
Ivan Aksentijevich, MD — Virginia Cancer Specialists
Daniel A. Arber, MD — University of Chicago
John Barrett, MD — National Institutes of Heath
Renier J. Brentjens, MD, PhD — Memorial Sloan-Kettering Cancer Center
Jill Brufsky, PharmD (Patient) — University of Pittsburgh Medical Center
Jorge Cortes, MD — Georgia Cancer Center
Marcos De Lima, MD — Case Western Reserve University
Stephen J. Forman, MD — City of Hope
Ephraim J. Fuchs, MD — Johns Hopkins
Linda J. Fukas — Nursing Professional
Steven D. Gore, MD — Yale University
Mark R. Litzow, MD — Mayo Clinic Cancer Center
Jeremy S. Miller, MD — University of Minnesota
John M. Pagel, MD, PhD — Swedish Cancer Institute
Edmund K. Waller, MD, PhD, FACP — Emory University
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com